TSS:Rfhg 220510.1

Basic information about the TSS

---

TSS ID: rfhg_220510.1 TSS ID(Version3): hg_184622.1 hg_184624.1 hg_184623.1 Species: human Chr: chr20		Start: 41028787 End: 41028886 Strand: +
Source datasets
Protocol
TSS cluster detected*

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3300008,EH38E2112936)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000361337.3:0 AK310516:0 AK225095:0 AK292943:0 BC039009:0 BC004475:0 BC067349:0 AK310508:0 J03250:0 GeneID: 7150 HGNC/MGI_ID: HGNC:11986 UniProt_ID: P11387 Q6NWZ5 Q6PK95 Nearer transcript ids and distances:

Gene_name: TOP1 Gene_symbol: TOP1 Gene_synonyms: Gene_source: HGNC:11986

TATA-Box annotation

---

Distance to TSS:	14
Nearest PromoterID:	NM_003286
Entrez ID:	7150
Nearest Unigene:	Hs.472737
Nearest Refseq:	NM_003286
Nearest Ensembl:	ENSG00000198900
Gene Name:	TOP1
Gene Alias:	TOPI
Gene Type:	protein-coding
CpG%:	0.090909
GC%:	0.610000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	1(TTGTTTAAAAGC,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TOP1 p2@TOP1 p3@TOP1
Sample		p1@TOP1	p2@TOP1	p3@TOP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	73.64	56.88	40.13
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.45	49.37	40.46
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	77.93	60.19	37.81
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	62.58	50.31	39.71
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	72.44	51.07	45.44
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	72.49	59.69	47.68
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	98.92	80.18	43.79
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	84.05	62.73	32.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	87.20	50.22	35.26
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	82.89	83.47	59.70
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	74.78	66.70	51.34
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	69.11	82.53	58.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	63.35	11.44	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	55.33	9.47	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	62.35	12.08	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	53.57	9.56	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	54.38	8.30	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.56	8.44	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	44.78	14.93	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	44.53	9.18	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.17	11.63	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.64	8.98	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	50.93	10.60	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.74	8.74	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	62.43	9.80	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	50.01	12.03	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	47.80	13.19	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	57.76	15.32	5.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	42.80	8.72	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.60	11.40	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	42.71	14.86	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	46.11	11.33	3.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	38.62	13.08	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	46.68	8.58	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	48.06	11.41	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	47.14	14.37	3.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	47.82	13.90	4.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	40.30	12.09	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.00	20.80	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	52.57	12.96	4.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	35.76	10.12	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.46	11.42	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	53.15	12.02	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	44.93	14.69	3.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	58.63	19.68	4.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	52.81	16.75	3.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	49.18	12.72	6.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	49.48	16.69	3.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	57.69	16.04	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	49.34	15.77	4.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	51.65	15.37	5.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	52.04	12.90	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1021.43	153.91	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	54.65	10.29	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	43.08	10.60	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	106.55	18.46	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	44.55	10.56	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	73.57	16.53	5.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	53.64	12.85	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	56.89	8.80	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	62.75	16.92	5.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	52.15	14.58	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	86.78	16.72	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	57.42	5.78	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	77.33	15.60	4.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	55.38	9.58	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1050.66	177.80	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	908.21	134.26	47.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.64	6.34	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	48.60	8.43	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	47.85	9.85	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	47.03	2.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	43.62	8.35	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	39.44	7.64	1.22
Adipocyte - breast, donor1	11376-118A8	18.21	10.45	6.02
Adipocyte - breast, donor2	11327-117E4	26.95	12.35	4.17
Adipocyte - omental, donor1	11473-119C6	25.83	12.60	7.12
Adipocyte - omental, donor2	11474-119C7	11.21	9.72	0.75
Adipocyte - omental, donor3	11475-119C8	9.38	12.06	2.68
Adipocyte - perirenal, donor1	11476-119C9	7.66	11.48	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.10	9.94	5.42
Adipocyte - subcutaneous, donor3	11408-118E4	13.55	6.43	3.82
Adipocyte differentiation, day04, donor1	13019-139D4	40.87	29.34	9.19
Adipocyte differentiation, day04, donor2	13022-139D7	49.16	21.88	11.32
Adipocyte differentiation, day04, donor3	13025-139E1	42.93	15.89	7.53
Adipocyte differentiation, day04, donor4	13028-139E4	63.48	31.74	9.40
Adipocyte differentiation, day08, donor1	13020-139D5	61.61	49.14	24.45
Adipocyte differentiation, day08, donor2	13023-139D8	43.89	19.69	6.78
Adipocyte differentiation, day08, donor3	13026-139E2	29.86	14.40	12.80
Adipocyte differentiation, day08, donor4	13029-139E5	50.08	23.37	9.46
Adipocyte differentiation, day12, donor1	13021-139D6	22.46	13.72	5.41
Adipocyte differentiation, day12, donor2	13024-139D9	31.90	16.58	5.02
Adipocyte differentiation, day12, donor3	13027-139E3	33.05	19.31	7.85
Adipocyte differentiation, day12, donor4	13030-139E6	35.93	20.40	11.27
Alveolar Epithelial Cells, donor1	11510-119G7	36.24	13.48	4.20
Alveolar Epithelial Cells, donor2	11590-120G6	5.74	4.66	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	5.99	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	19.43	8.10	1.80
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.61	5.96	1.64
Anulus Pulposus Cell, donor1	11248-116E6	47.72	11.10	4.12
Anulus Pulposus Cell, donor2	11463-119B5	24.25	9.80	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	41.34	12.13	3.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	44.72	12.16	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	10.70	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.27	8.37	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	43.00	12.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	10.56	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	33.79	12.67	2.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	39.81	7.28	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.32	4.16	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	44.44	9.42	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	39.19	8.71	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	1.25	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.84	9.88	3.95
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	6.82	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.67	10.40	2.56
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	8.04	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.75	9.26	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	36.08	8.29	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	35.12	9.75	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.21	8.79	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	36.19	8.75	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	12.58	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	35.92	7.77	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	28.84	9.87	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	7.27	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.21	6.27	3.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.71	8.76	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	28.65	6.19	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.09	11.73	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	33.44	11.58	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	29.25	7.85	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	33.93	12.28	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.52	9.03	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	40.39	7.13	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	46.28	14.24	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	38.46	12.23	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	5.72	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	34.52	11.22	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	32.18	9.53	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	28.42	7.54	3.77
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	44.40	10.39	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	28.48	8.48	2.54
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	11.58	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	8.45	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.66	12.01	3.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	40.91	12.03	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	5.83	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.28	8.74	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	28.22	7.12	2.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.65	8.67	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.82	6.12	3.98
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	34.89	12.43	5.26
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	32.37	10.87	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	3.05	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.59	11.08	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.16	12.71	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	32.71	12.36	4.36
Astrocyte - cerebellum, donor1	11500-119F6	41.88	10.32	1.72
Astrocyte - cerebellum, donor2	11580-120F5	26.53	8.22	0.51
Astrocyte - cerebellum, donor3	11661-122F5	17.41	3.99	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	69.72	29.28	8.37
Astrocyte - cerebral cortex, donor2	11316-117D2	118.74	30.09	9.71
Astrocyte - cerebral cortex, donor3	11392-118C6	78.91	21.03	9.40
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	305.64	53.44	21.56
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	366.95	74.17	27.81
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	373.25	69.07	26.63
Basophils, donor1	12241-129G9	29.81	38.97	25.63
Basophils, donor2	12242-129H1	74.68	55.92	41.13
Basophils, donor3	12243-129H2	38.07	40.13	24.55
Bronchial Epithelial Cell, donor1	11511-119G8	13.58	3.67	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	1.83	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	9.41	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	16.64	5.41	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	13.13	3.68	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	49.30	5.40	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	228.78	52.35	14.84
Burkitt's lymphoma cell line:RAJI	10476-106I8	261.09	47.75	12.58
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	83.46	19.19	9.59
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	62.05	0.00
CD14+ Monocytes, donor1	11224-116B9	42.83	89.04	74.39
CD14+ Monocytes, donor2	11305-117B9	96.88	107.65	90.57
CD14+ Monocytes, donor3	11381-118B4	67.62	88.69	63.45
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	59.16	17.55	4.53
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	63.31	15.54	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	25.31	6.90
CD14+ monocytes - mock treated, donor1	11863-125A9	108.27	70.68	34.11
CD14+ monocytes - mock treated, donor2	11873-125C1	115.57	55.22	33.49
CD14+ monocytes - mock treated, donor3	11883-125D2	129.82	64.43	34.82
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	97.43	68.63	40.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	128.62	63.48	30.09
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	118.76	81.07	38.43
CD14+ monocytes - treated with BCG, donor1	11860-125A6	271.97	137.45	87.52
CD14+ monocytes - treated with BCG, donor2	11870-125B7	244.46	108.97	69.80
CD14+ monocytes - treated with BCG, donor3	11880-125C8	292.93	112.95	80.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	136.73	87.33	64.15
CD14+ monocytes - treated with Candida, donor2	11878-125C6	188.51	106.13	64.42
CD14+ monocytes - treated with Candida, donor3	11888-125D7	135.34	79.87	57.69
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	102.49	71.99	38.53
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	130.11	59.07	27.94
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	120.55	56.42	34.77
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	153.74	105.93	71.15
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	207.66	90.03	64.69
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	206.88	97.77	69.40
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	355.87	160.05	81.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	282.63	133.29	76.41
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	360.22	144.76	95.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	124.00	86.53	52.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	201.85	104.98	45.44
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	221.12	120.21	59.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	245.87	134.09	78.47
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	204.79	113.73	60.58
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	285.17	126.10	86.44
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	110.97	64.70	36.85
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	173.39	73.94	41.72
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	150.56	65.89	41.06
CD14+CD16+ Monocytes, donor1	11789-124B7	27.25	18.09	11.33
CD14+CD16+ Monocytes, donor2	11801-124D1	24.02	20.10	17.56
CD14+CD16+ Monocytes, donor3	11912-125G4	20.36	17.76	12.35
CD14+CD16- Monocytes, donor1	11788-124B6	63.07	41.89	32.08
CD14+CD16- Monocytes, donor2	11799-124C8	47.85	28.64	16.42
CD14+CD16- Monocytes, donor3	11910-125G2	109.92	50.17	18.06
CD14-CD16+ Monocytes, donor1	11790-124B8	20.67	26.03	19.14
CD14-CD16+ Monocytes, donor2	11800-124C9	23.71	21.96	16.91
CD14-CD16+ Monocytes, donor3	11911-125G3	23.37	17.69	16.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	77.23	8.13	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	59.66	10.85	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	79.74	11.39	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	62.37	15.46	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	87.92	11.79	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	79.32	5.62	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	73.73	10.98	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	68.55	11.86	3.95
CD19+ B Cells, donor1	11544-120B5	155.34	36.16	8.22
CD19+ B Cells, donor2	11624-122B4	121.87	31.92	10.16
CD19+ B Cells, donor3	11705-123B4	147.91	34.83	10.10
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1058.23	185.46	46.06
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	622.81	104.67	21.97
CD34+ Progenitors, donor1	11545-120B6	54.22	21.09	14.06
CD34+ Progenitors, donor2	11625-122B5	56.74	35.96	11.80
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	70.27	25.55	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	98.76	18.26	10.15
CD4+ T Cells, donor1	11225-116C1	127.47	80.69	38.92
CD4+ T Cells, donor2	11306-117C1	174.52	83.28	36.13
CD4+ T Cells, donor3	11382-118B5	121.69	62.22	24.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	87.55	6.89	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	108.48	10.56	4.27
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	95.44	11.21	3.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	106.67	38.88	11.38
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	98.33	35.12	11.24
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	102.18	26.37	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	71.54	12.57	4.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	102.69	15.93	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	99.46	15.80	5.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	66.80	30.48	8.52
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	68.48	20.26	6.99
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	95.04	19.80	6.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	93.18	11.38	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	99.52	11.01	4.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	82.53	11.69	3.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	110.68	28.55	8.43
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	127.56	36.44	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	125.53	23.31	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	95.31	13.35	3.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	74.73	12.13	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	68.93	12.40	4.20
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	78.87	28.82	10.11
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	84.05	28.16	8.23
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	115.49	23.97	4.36
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	84.13	14.35	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	54.47	10.16	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	67.00	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	69.23	16.62	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	67.73	16.20	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	86.24	13.86	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	94.54	15.76	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	72.02	12.46	0.00
CD8+ T Cells, donor1	11226-116C2	84.14	74.65	36.67
CD8+ T Cells, donor2	11307-117C2	124.64	91.98	33.41
CD8+ T Cells, donor3	11383-118B6	139.37	97.71	42.17
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	91.76	27.53	17.89
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	102.33	25.88	17.49
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	113.54	32.83	20.52
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	121.29	39.93	29.12
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	113.27	34.32	20.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	104.14	29.11	21.15
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	87.13	30.64	14.12
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	95.54	30.79	17.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	102.95	33.30	15.95
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	119.54	34.11	13.28
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	122.59	34.57	15.69
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	95.65	34.10	16.52
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	241.20	99.81	51.65
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	252.76	116.13	55.56
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	378.16	164.09	76.82
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	100.48	36.02	19.81
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	102.72	35.10	20.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	104.18	40.30	18.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	99.19	39.61	20.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	97.81	35.06	23.37
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	97.46	34.62	20.52
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	103.27	43.22	18.74
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	98.53	44.53	18.13
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	108.17	31.01	20.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	305.12	126.87	49.78
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	332.93	135.69	67.15
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	311.54	133.23	65.11
Cardiac Myocyte, donor1	11525-119I4	73.11	21.93	3.66
Cardiac Myocyte, donor2	11605-120I3	47.43	25.69	7.91
Cardiac Myocyte, donor3	11686-122I3	25.68	13.36	3.26
Chondrocyte - de diff, donor1	11261-116G1	17.68	14.56	1.73
Chondrocyte - de diff, donor2	11338-117F6	7.82	5.69	3.55
Chondrocyte - de diff, donor3	11410-118E6	13.54	5.23	1.59
Chondrocyte - re diff, donor2	11339-117F7	36.71	23.28	8.06
Chondrocyte - re diff, donor3	11411-118E7	17.39	7.68	5.66
Ciliary Epithelial Cells, donor1	11242-116D9	109.94	22.26	5.39
Ciliary Epithelial Cells, donor2	11323-117D9	89.14	13.47	7.48
Ciliary Epithelial Cells, donor3	11399-118D4	82.92	17.79	6.11
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	46.95	9.90	3.03
Corneal Epithelial Cells, donor1	11526-119I5	10.98	4.39	0.44
Corneal Epithelial Cells, donor2	11606-120I4	26.16	4.55	2.28
Corneal Epithelial Cells, donor3	11687-122I4	17.89	5.88	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	75.78	11.23	3.63
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	63.71	8.83	2.84
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	10.35	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	42.98	5.29	3.02
Dendritic Cells - plasmacytoid, donor1	11228-116C4	63.20	34.51	12.64
Dendritic Cells - plasmacytoid, donor2	11309-117C4	62.68	33.30	12.40
Dendritic Cells - plasmacytoid, donor3	11385-118B8	59.04	34.36	4.36
Endothelial Cells - Aortic, donor0	11207-116A1	24.35	5.67	3.34
Endothelial Cells - Aortic, donor1	11263-116G3	34.62	8.21	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	48.36	16.40	3.39
Endothelial Cells - Aortic, donor3	11412-118E8	46.00	10.62	4.33
Endothelial Cells - Artery, donor1	11264-116G4	41.89	11.34	2.04
Endothelial Cells - Artery, donor2	11341-117F9	75.29	22.59	10.35
Endothelial Cells - Artery, donor3	11413-118E9	39.09	12.97	4.73
Endothelial Cells - Lymphatic, donor1	11236-116D3	44.33	11.08	4.88
Endothelial Cells - Lymphatic, donor2	11317-117D3	51.73	15.52	3.96
Endothelial Cells - Lymphatic, donor3	11393-118C7	53.84	15.50	3.38
Endothelial Cells - Microvascular, donor1	11265-116G5	14.56	8.32	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	23.95	9.37	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	12.90	4.68	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	67.22	36.41	5.20
Endothelial Cells - Thoracic, donor2	11343-117G2	31.97	7.34	3.67
Endothelial Cells - Umbilical vein, donor1	11243-116E1	134.81	32.68	10.56
Endothelial Cells - Umbilical vein, donor2	11324-117E1	122.54	28.03	5.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	119.32	35.66	13.80
Endothelial Cells - Vein, donor1	11267-116G7	17.06	5.69	2.28
Endothelial Cells - Vein, donor2	11344-117G3	21.65	8.38	0.70
Endothelial Cells - Vein, donor3	11416-118F3	36.90	10.83	5.18
Eosinophils, donor1	12244-129H3	60.99	15.25	15.25
Eosinophils, donor2	12245-129H4	359.76	341.60	123.77
Eosinophils, donor3	12246-129H5	313.88	249.68	142.67
Esophageal Epithelial Cells, donor1	11507-119G4	10.26	4.64	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.12	10.67	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.34	5.80	2.52
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.30	4.66	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	39.42	11.40	4.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	64.01	26.07	12.28
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.11	11.29	3.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	50.59	20.29	4.22
Fibroblast - Aortic Adventitial, donor3	11401-118D6	38.54	14.95	4.32
Fibroblast - Cardiac, donor1	11268-116G8	29.03	9.07	1.36
Fibroblast - Cardiac, donor2	11345-117G4	15.16	5.31	3.79
Fibroblast - Cardiac, donor3	11417-118F4	19.40	6.78	2.37
Fibroblast - Cardiac, donor4	11452-119A3	71.84	25.46	8.79
Fibroblast - Cardiac, donor5	11456-119A7	36.17	20.05	4.31
Fibroblast - Cardiac, donor6	11460-119B2	48.36	22.74	3.79
Fibroblast - Choroid Plexus, donor1	11492-119E7	37.38	16.75	2.55
Fibroblast - Choroid Plexus, donor2	11572-120E6	57.81	13.81	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	65.92	20.51	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	85.34	33.90	11.30
Fibroblast - Conjunctival, donor3	11692-122I9	32.90	15.77	2.54
Fibroblast - Dermal, donor1	11269-116G9	50.95	9.39	3.99
Fibroblast - Dermal, donor2	11346-117G5	47.64	11.79	6.60
Fibroblast - Dermal, donor3	11418-118F5	41.22	14.63	6.29
Fibroblast - Dermal, donor4	11450-119A1	83.99	30.18	4.18
Fibroblast - Dermal, donor5	11454-119A5	83.21	36.98	5.06
Fibroblast - Dermal, donor6	11458-119A9	87.71	38.33	6.98
Fibroblast - Gingival, donor1	11237-116D4	126.60	35.40	13.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	70.22	13.36	4.98
Fibroblast - Gingival, donor2	11318-117D4	154.45	27.41	10.41
Fibroblast - Gingival, donor3	11394-118C8	90.69	32.58	11.02
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	23.89	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	38.76	11.98	5.81
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	66.57	22.14	6.55
Fibroblast - Gingival, donor6 (control)	11922-125H5	83.84	15.69	5.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	129.86	15.53	5.29
Fibroblast - Gingival, donor7 (control)	11924-125H7	70.20	14.48	2.92
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	73.90	13.91	3.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	84.68	20.95	4.83
Fibroblast - Gingival, donor9 (control)	11927-125I1	42.11	16.87	3.67
Fibroblast - Lung, donor1	11270-116H1	33.98	8.16	1.36
Fibroblast - Lung, donor2	11347-117G6	111.91	31.34	11.94
Fibroblast - Lung, donor3	11419-118F6	108.05	21.10	14.77
Fibroblast - Lymphatic, donor1	11506-119G3	51.65	19.99	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	19.58	11.19	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	12.31	3.64	0.28
Fibroblast - Mammary, donor1	11540-120B1	105.96	34.91	10.15
Fibroblast - Mammary, donor2	11620-122A9	47.93	23.97	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	98.15	23.47	9.89
Fibroblast - Periodontal Ligament, donor2	11319-117D5	223.28	50.06	19.26
Fibroblast - Periodontal Ligament, donor3	11395-118C9	177.78	49.88	21.11
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	54.95	11.07	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	32.94	10.26	3.24
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	35.37	15.19	8.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	48.41	12.82	5.31
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	53.64	22.35	9.96
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	40.76	10.02	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.35	11.86	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	79.18	30.56	5.75
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.89	6.22	2.13
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.59	14.78	6.50
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	50.54	22.26	3.61
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.02	19.76	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	56.44	20.50	3.54
Fibroblast - skin normal, donor1	11553-120C5	26.42	8.86	1.97
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	82.01	23.26	4.21
Fibroblast - skin normal, donor2	11561-120D4	29.44	11.55	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	72.84	29.01	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	32.72	13.50	4.23
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.52	12.48	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	61.75	18.72	5.25
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	28.44	12.04	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	30.03	11.47	2.70
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.72	4.70	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	88.64	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	133.34	20.05	4.36
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.47	10.23	5.89
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	54.91	13.27	8.07
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	67.20	19.16	8.18
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	78.85	15.31	16.84
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	75.29	26.80	8.93
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	150.33	35.09	14.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	159.66	20.96	5.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	144.07	26.26	9.82
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	121.65	28.33	11.69
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	159.13	19.56	3.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	174.16	31.64	17.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.92	28.74	8.84
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	70.52	24.17	7.07
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	65.88	24.26	6.16
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	102.88	20.68	9.40
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	75.58	30.48	8.30
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	95.65	32.81	10.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	133.16	28.06	10.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	79.63	16.20	5.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	67.14	21.67	8.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	137.05	23.39	6.56
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	76.82	16.55	6.21
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	64.38	21.30	7.63
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	82.00	16.31	4.24
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	76.02	20.97	9.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	67.35	27.82	9.33
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	120.06	28.82	16.23
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	103.85	27.37	11.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	82.83	19.64	7.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	57.10	20.80	6.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	74.96	23.13	9.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	75.14	20.42	10.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	66.43	17.74	4.75
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	56.61	18.10	7.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	61.37	19.51	9.01
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	61.06	14.11	6.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	50.06	18.33	5.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	78.94	22.69	9.56
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	72.16	14.43	3.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.94	15.92	4.55
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	51.09	13.76	6.49
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	58.08	17.33	3.34
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.25	19.34	5.75
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	49.40	11.20	5.49
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	62.56	13.47	5.05
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.83	15.74	6.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	50.81	16.85	8.29
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	58.29	20.35	8.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.02	12.31	5.96
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.62	14.91	5.42
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	53.83	12.17	5.16
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	52.20	13.82	4.39
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	149.75	31.74	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.71	10.82	3.83
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.79	9.08	4.24
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	114.37	29.48	7.88
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	87.98	39.61	5.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	75.65	26.96	6.32
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	86.13	38.46	14.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	70.41	17.84	8.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	68.10	22.04	7.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	117.15	27.67	5.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	108.89	24.75	14.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	146.60	27.08	8.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	105.89	35.30	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	106.07	29.56	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	110.66	22.13	6.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	126.83	34.59	8.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	143.29	19.99	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	119.13	22.65	5.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	121.91	24.84	5.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	133.38	20.13	8.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	132.64	23.54	10.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	112.09	22.08	7.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	91.88	16.71	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	111.10	19.47	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	83.76	15.69	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	93.18	15.25	18.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	124.26	31.89	13.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	127.26	30.61	10.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	100.10	15.81	26.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	91.11	12.30	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	87.03	18.58	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	57.52	16.05	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	87.46	18.49	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	135.22	47.59	15.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	131.69	12.42	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	94.84	18.87	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	91.13	16.29	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	86.47	17.29	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	109.68	23.13	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	83.38	13.32	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	116.86	20.07	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	86.93	15.75	5.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	79.44	10.09	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	105.96	19.50	7.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	71.03	15.52	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	59.69	19.90	6.79
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.35	7.07	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	3.37	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.35	9.83	4.12
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.30	2.51	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	48.16	8.70	3.25
Hep-2 cells mock treated, biol_rep2	11899-125E9	58.24	8.10	4.22
Hep-2 cells mock treated, biol_rep3	11900-125F1	59.15	7.51	4.78
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	53.01	8.64	4.70
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	53.73	7.95	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	55.33	8.61	3.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	43.34	7.85	2.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	46.83	6.52	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	48.38	5.13	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	27.98	8.95	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.37	6.92	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	2.64	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.11	7.76	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	5.81	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	39.16	9.79	2.80
Hepatocyte, donor1	11523-119I2	62.95	12.11	3.63
Hepatocyte, donor2	11603-120I1	50.63	21.55	14.01
Hepatocyte, donor3	11684-122I1	57.67	24.54	9.20
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	262.38	68.53	32.63
Intestinal epithelial cells (polarized), donor1	11246-116E4	145.59	39.15	9.61
Iris Pigment Epithelial Cells, donor1	11530-119I9	74.91	23.33	8.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	12.74	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	54.17	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	4.15	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	7.51	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	10.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	40.61	3.25	9.75
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	10.59	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	32.15	9.98	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	26.45	9.45	3.78
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	7.73	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	8.40	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	8.05	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	21.19	7.33	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.11	6.72	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	12.86	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	31.39	9.23	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.35	8.02	6.61
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	2.72	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	12.91	6.46
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	5.08	6.35
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.03	8.29	6.38
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	10.94	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	5.71	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	28.09	6.17	4.32
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	1.76	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	9.43	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	24.34	8.34	4.87
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	11.07	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	12.97	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.05	9.59	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	2.25	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	5.33	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	5.54	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	19.95	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	20.25	7.36	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	4.23	5.29
Keratinocyte - epidermal, donor1	11272-116H3	59.00	11.83	4.98
Keratinocyte - epidermal, donor2	11349-117G8	11.13	4.10	1.17
Keratinocyte - epidermal, donor3	11421-118F8	60.01	14.39	3.79
Keratinocyte - oral, donor1	11251-116E9	102.51	18.62	6.02
Keratocytes, donor1	11527-119I6	74.27	40.57	19.60
Keratocytes, donor2	11607-120I5	33.98	9.37	3.52
Keratocytes, donor3	11688-122I5	50.58	25.09	7.11
Krukenberg tumor cell line:HSKTC	10687-109F3	208.80	8.79	4.40
Lens Epithelial Cells, donor1	11529-119I8	85.22	17.26	3.24
Lens Epithelial Cells, donor2	11609-120I7	63.55	15.69	4.15
Lens Epithelial Cells, donor3	11690-122I7	68.11	20.28	7.57
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	27.39	5.81	4.03
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.26	5.58	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.17	15.43	4.88
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.97	6.45	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	6.62	3.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.66	4.74	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.14	8.62	4.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.40	1.52	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.76	6.47	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	32.04	5.54	3.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.79	10.86	5.23
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.26	2.59	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.53	5.92	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.85	9.06	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.09	5.36	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	26.48	11.39	5.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.47	3.74	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	17.20	4.39	2.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.10	9.22	3.62
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.52	3.22	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.95	4.23	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	27.64	8.73	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.04	8.62	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.89	6.66	2.27
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	26.44	5.70	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	37.27	9.42	3.77
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.03	5.71	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	29.58	6.19	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.93	6.02	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.60	4.24	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.56	10.66	3.88
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	8.60	1.98
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	13.38	4.96	1.61
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.84	12.96	4.81
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.26	4.45	2.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.49	4.67	1.92
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.34	7.72	3.86
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	36.52	8.83	4.56
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.53	8.68	2.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.62	7.82	3.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	2.91	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.65	3.73	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.05	5.01	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.99	5.23	2.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.77	2.83	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	26.98	8.66	3.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.22	5.12	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.01	3.28	2.09
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	2.27	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	46.80	5.37	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	39.34	5.20	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	60.51	3.39	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.28	3.52	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	40.16	5.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.34	3.61	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	45.20	3.57	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	32.35	4.07	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	95.39	13.38	4.07
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	90.03	12.15	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	53.65	8.94	3.93
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	52.89	5.14	4.62
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	81.51	8.82	4.23
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	95.28	8.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	78.95	7.64	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	90.45	10.14	5.34
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	109.78	13.60	3.78
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	63.20	3.07	6.75
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	78.28	4.89	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	112.03	14.16	5.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	102.86	12.33	6.45
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	43.27	7.21	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	100.15	10.74	4.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	90.87	10.46	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	105.67	8.30	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	71.40	6.72	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	84.08	11.80	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	6.91	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	65.24	8.83	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	53.78	5.10	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	51.69	13.13	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	55.13	4.97	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	69.66	9.34	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	99.34	8.96	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	58.34	6.69	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	87.44	8.18	4.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	61.65	3.43	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	78.30	7.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.26	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	54.75	7.11	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	54.99	4.81	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	48.84	5.37	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	57.91	3.37	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	65.19	7.41	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	69.78	5.81	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	47.60	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	73.23	5.60	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.07	6.54	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	49.06	6.13	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.85	4.93	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	51.75	11.29	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	59.33	5.53	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	59.03	4.96	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	68.84	10.33	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	70.36	6.23	4.01
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	91.50	6.65	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	69.93	7.92	8.58
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	86.14	9.34	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	91.89	9.19	6.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	107.91	20.13	8.39
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	89.21	6.62	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	102.60	8.87	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	117.47	16.71	7.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	112.95	17.78	7.21
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	92.23	9.54	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	95.40	12.15	4.25
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	74.01	17.29	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	99.56	9.12	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	94.50	7.23	4.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	78.61	8.47	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	95.39	8.24	5.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	83.16	9.06	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	49.42	6.90	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	81.76	7.71	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.27	7.78	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	44.26	5.11	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	83.62	7.49	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	67.34	3.92	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	48.44	7.93	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	70.62	10.69	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	54.86	5.35	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	67.90	9.62	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	63.44	7.27	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	43.13	7.34	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	47.12	9.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	54.71	6.27	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	47.55	5.37	6.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	83.72	10.40	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	47.66	5.35	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	48.35	7.54	2.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	45.75	6.63	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	72.75	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	43.76	9.80	4.10
Macrophage - monocyte derived, donor2	11313-117C8	29.54	9.36	4.59
Macrophage - monocyte derived, donor3	11389-118C3	34.34	12.06	5.24
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	34.52	7.97	6.37
Mallassez-derived cells, donor2	11929-125I3	58.47	15.53	6.18
Mallassez-derived cells, donor3	11930-125I4	64.21	16.96	7.51
Mammary Epithelial Cell, donor1	11273-116H4	77.42	24.21	12.46
Mammary Epithelial Cell, donor2	11350-117G9	82.52	15.64	6.66
Mammary Epithelial Cell, donor3	11422-118F9	14.47	3.74	1.50
Mast cell - stimulated, donor1	11487-119E2	2220.24	291.51	107.79
Mast cell, donor1	11563-120D6	68.56	12.54	3.46
Mast cell, donor2	11565-120D8	82.61	17.24	2.97
Mast cell, donor3	11566-120D9	88.70	17.11	4.95
Mast cell, donor4	11567-120E1	70.92	14.54	3.55
Mast cell, expanded and stimulated, donor5	11940-126A5	92.71	10.31	2.00
Mast cell, expanded and stimulated, donor8	11942-126A7	64.79	8.17	0.58
Mast cell, expanded, donor5	11939-126A4	69.29	8.03	1.15
Mast cell, expanded, donor8	11941-126A6	88.54	10.38	1.51
Melanocyte - dark, donor1	11502-119F8	39.90	11.34	4.68
Melanocyte - dark, donor2	11582-120F7	49.14	15.23	6.92
Melanocyte - dark, donor3	11663-122F7	33.40	11.30	2.83
Melanocyte - light, donor1	11274-116H5	14.34	3.06	1.41
Melanocyte - light, donor2	11351-117H1	6.14	1.36	0.00
Melanocyte - light, donor3	11423-118G1	16.48	3.47	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	32.70	9.48	2.19
Melanocyte, donor2 (MC+2)	12739-135I3	40.88	8.61	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	79.02	11.79	3.21
Meningeal Cells, donor1	11493-119E8	72.95	34.12	4.84
Meningeal Cells, donor2	11573-120E7	51.06	29.93	9.68
Meningeal Cells, donor3	11654-122E7	127.39	36.92	15.81
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	118.34	25.66	9.98
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	49.51	14.29	6.14
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	6.57	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	5.23	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	64.58	15.79	10.05
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.39	11.44	3.39
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	47.75	8.54	6.53
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	60.21	14.50	7.91
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	94.98	16.07	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	71.82	11.66	5.52
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.19	12.60	1.66
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.59	11.90	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	54.08	23.16	6.58
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	35.31	18.40	10.98
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	14.01	7.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.22	17.29	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	48.91	25.52	13.11
Mesenchymal stem cells - hepatic, donor0	11218-116B3	41.59	20.33	5.32
Mesenchymal stem cells - umbilical, donor0	11214-116A8	62.41	18.14	3.63
Mesothelial Cells, donor1	11247-116E5	38.72	19.62	8.49
Mesothelial Cells, donor2	12156-128G5	41.54	11.01	4.00
Mesothelial Cells, donor3	11402-118D7	39.75	14.24	8.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	137.73	44.56	12.15
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	59.11	13.30	3.20
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.63	13.25	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	13.83	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.15	8.99	3.41
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.89	4.77	3.73
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	6.95	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	43.55	12.26	3.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	42.82	13.50	4.19
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	38.41	10.16	3.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.86	6.73	5.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	42.48	6.19	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	33.81	6.08	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	73.69	18.42	14.47
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.96	10.40	2.97
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	30.39	9.21	3.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	46.50	12.22	4.47
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	55.33	16.77	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	54.20	11.79	2.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.03	9.98	6.18
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	82.93	31.51	13.82
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	63.78	15.89	7.83
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	43.54	10.31	5.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	69.51	20.38	11.01
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	61.57	11.80	5.36
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	72.24	21.34	10.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	30.96	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	83.66	23.65	10.07
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	100.88	26.36	14.19
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	132.56	38.11	24.85
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	141.33	29.08	21.20
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	71.17	20.29	13.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	131.93	41.43	29.44
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	94.19	15.38	8.65
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	67.24	21.21	8.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	200.20	43.88	34.28
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	94.11	28.53	10.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	108.04	18.35	18.35
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	91.53	27.59	14.45
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	108.16	25.38	9.93
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	124.88	54.43	24.98
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	116.27	29.01	18.84
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	108.56	28.53	16.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	95.02	41.99	24.31
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	59.83	18.46	9.91
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	102.84	24.94	14.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	63.92	40.48	21.66
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	57.51	20.48	8.98
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	74.81	25.77	11.64
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	86.83	32.05	20.98
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	54.90	21.72	12.07
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	56.77	18.78	9.60
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	36.09	21.66
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	53.57	16.62	9.24
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	79.11	26.18	7.40
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	43.53	31.23	17.27
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	42.50	17.88	10.88
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	72.07	23.59	9.01
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	56.53	28.58	16.51
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	65.39	24.02	10.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	50.89	21.25	9.58
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	29.95	21.47	14.83
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	39.18	15.93	10.51
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	52.85	24.77	9.95
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	49.68	23.89	11.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	52.28	15.34	9.94
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	41.29	14.50	9.34
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	56.70	23.46	11.73
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	48.51	17.94	5.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	46.13	23.35	2.88
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	57.29	31.74	12.78
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	35.14	18.16	6.55
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	1.78	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	51.91	10.19	4.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	39.97	4.21	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	29.26	7.51	1.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	31.66	4.66	3.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	43.94	10.14	6.01
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.63	6.39	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	30.65	7.69	2.94
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	31.68	7.37	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	56.80	14.66	5.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	17.11	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.65	6.41	5.34
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	5.05	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	31.62	5.90	7.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	62.65	23.15	14.98
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.71	4.45	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.87	6.48	6.48
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	51.35	21.15	13.59
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	182.73	68.52	28.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	140.29	75.04	35.89
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	80.79	28.51	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	125.49	112.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.75	9.05	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.13	3.66	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	146.18	34.71	14.02
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	154.84	27.13	10.85
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	157.63	17.30	11.22
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	370.24	81.39	22.34
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	97.91	18.36	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	597.23	86.37	60.64
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	60.69	10.04	5.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	102.27	23.01	9.30
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	99.44	21.08	6.76
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	76.11	12.61	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1146.88	178.16	89.08
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	60.06	11.42	5.96
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	42.77	10.83	3.25
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	60.07	13.15	6.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	67.61	21.39	4.08
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	54.13	16.95	5.47
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.57	15.38	7.96
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	54.63	11.41	7.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	75.15	17.72	6.56
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	55.94	12.03	4.07
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	97.19	34.39	9.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	57.66	14.77	7.74
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	54.71	11.49	4.60
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	52.38	13.18	3.53
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	61.73	18.28	7.24
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	543.62	106.19	32.87
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	75.30	27.18	6.91
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	61.82	16.94	4.23
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	57.68	7.12	2.61
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	49.36	19.75	5.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	893.75	243.75	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	72.98	21.99	3.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	58.16	22.09	5.41
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	43.25	12.30	6.75
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	41.79	16.72	7.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	62.81	10.97	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	61.92	18.90	4.24
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	98.92	20.92	5.67
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	92.72	23.07	5.88
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	77.61	11.46	7.06
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	69.14	15.29	7.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	57.54	20.34	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	78.86	16.84	5.36
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	52.32	9.68	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	53.93	15.03	2.87
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	67.09	13.55	10.16
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	424.09	102.19	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	54.26	14.63	6.10
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	70.19	12.90	2.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	97.76	10.29	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	36.39	12.66	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	90.69	15.87	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	338.88	65.75	30.35
Myoblast, donor1	11241-116D8	66.96	13.17	10.31
Myoblast, donor2	11322-117D8	93.21	17.45	10.93
Myoblast, donor3	11398-118D3	63.23	18.50	9.42
NK T cell leukemia cell line:KHYG-1	10777-110G3	106.97	79.97	34.44
Natural Killer Cells, donor1	11230-116C6	79.65	69.19	35.98
Natural Killer Cells, donor2	11311-117C6	114.29	73.58	32.27
Natural Killer Cells, donor3	11387-118C1	98.10	73.99	35.34
Neural stem cells, donor1	11275-116H6	211.96	54.80	25.77
Neural stem cells, donor2	11352-117H2	200.27	51.99	25.03
Neurons, donor1	11494-119E9	105.82	29.59	7.97
Neurons, donor2	11574-120E8	86.52	24.88	5.50
Neurons, donor3	11655-122E8	132.37	32.06	12.33
Neutrophils, donor1	11233-116C9	232.00	229.22	90.94
Neutrophils, donor2	11314-117C9	171.03	150.74	60.88
Neutrophils, donor3	11390-118C4	290.76	339.02	136.22
Nucleus Pulposus Cell, donor1	11252-116F1	57.47	19.24	5.22
Nucleus Pulposus Cell, donor2	11409-118E5	30.28	13.02	2.60
Nucleus Pulposus Cell, donor3	11462-119B4	41.92	23.67	2.81
Olfactory epithelial cells, donor1	11933-125I7	33.17	11.70	3.85
Olfactory epithelial cells, donor2	11934-125I8	50.52	12.59	3.62
Olfactory epithelial cells, donor3	11935-125I9	38.14	11.35	2.95
Olfactory epithelial cells, donor4	11936-126A1	51.43	11.59	3.02
Oligodendrocyte - precursors, donor1	11496-119F2	74.02	22.87	6.02
Osteoblast - differentiated, donor1	11276-116H7	17.44	5.96	2.55
Osteoblast - differentiated, donor2	11353-117H3	18.29	2.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	22.97	4.34	1.24
Osteoblast, donor1	11277-116H8	14.46	4.69	2.15
Osteoblast, donor2	11354-117H4	75.15	22.47	7.02
Osteoblast, donor3	11426-118G4	22.39	7.64	3.73
Pancreatic stromal cells, donor1	11249-116E7	62.17	18.11	6.57
Pericytes, donor1	11491-119E6	12.91	4.34	0.67
Pericytes, donor2	11571-120E5	13.36	8.60	0.91
Pericytes, donor3	11652-122E5	25.84	8.14	2.64
Perineurial Cells, donor1	11499-119F5	77.65	21.47	4.63
Perineurial Cells, donor2	11579-120F4	61.46	28.34	10.58
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	88.93	57.69	25.50
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	97.70	58.52	38.69
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	74.28	49.18	25.49
Placental Epithelial Cells, donor1	11278-116H9	11.72	3.35	0.96
Placental Epithelial Cells, donor2	11355-117H5	6.65	4.44	1.11
Placental Epithelial Cells, donor3	11427-118G5	10.99	3.73	1.96
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.91	1.90	1.27
Preadipocyte - breast, donor1	11467-119B9	17.45	3.94	3.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	39.03	15.79	4.83
Preadipocyte - breast, donor2	11328-117E5	14.18	5.63	1.58
Preadipocyte - omental, donor1	11468-119C1	23.66	9.06	4.90
Preadipocyte - omental, donor2	11329-117E6	20.08	13.97	6.11
Preadipocyte - omental, donor3	11403-118D8	25.21	13.47	4.44
Preadipocyte - perirenal, donor1	11469-119C2	5.91	3.94	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.58	2.76	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	103.24	26.03	9.56
Preadipocyte - subcutaneous, donor3	11428-118G6	42.23	15.67	4.94
Preadipocyte - visceral, donor1	11280-116I2	94.64	26.92	8.38
Preadipocyte - visceral, donor2	11357-117H7	104.46	22.09	12.89
Preadipocyte - visceral, donor3	11429-118G7	54.75	18.81	2.82
Prostate Epithelial Cells (polarized), donor1	11253-116F2	114.50	46.31	25.04
Prostate Epithelial Cells, donor2	11331-117E8	43.33	9.75	4.47
Prostate Epithelial Cells, donor3	11404-118D9	58.91	12.37	4.35
Prostate Stromal Cells, donor1	11254-116F3	54.90	15.03	6.61
Prostate Stromal Cells, donor2	11332-117E9	65.09	17.75	9.68
Prostate Stromal Cells, donor3	11405-118E1	28.26	10.53	4.38
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.20	6.20	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	53.79	13.79	3.05
Renal Epithelial Cells, donor1	11517-119H5	21.30	7.10	1.01
Renal Epithelial Cells, donor2	11597-120H4	22.05	9.25	1.42
Renal Epithelial Cells, donor3	11678-122H4	66.80	14.50	3.39
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	6.13	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	22.37	9.30	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	93.02	13.54	3.77
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.97	4.66	3.33
Renal Mesangial Cells, donor1	11518-119H6	27.73	7.48	2.64
Renal Mesangial Cells, donor2	11598-120H5	20.06	2.51	1.25
Renal Mesangial Cells, donor3	11679-122H5	12.48	1.66	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	46.71	15.84	4.03
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.88	6.33	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	36.06	9.84	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	73.64	18.15	6.22
Retinal Pigment Epithelial Cells, donor1	11528-119I7	32.97	7.39	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	10.29	6.17
Retinal Pigment Epithelial Cells, donor3	11689-122I6	81.04	17.56	7.03
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	113.46	39.29	13.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	76.83	10.72	4.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	188.78	31.92	8.26
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	435.62	70.77	19.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	95.83	33.68	4.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	95.63	27.31	8.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	91.24	22.53	9.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	119.95	32.13	4.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	102.91	22.73	7.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	134.29	30.51	13.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	75.57	27.11	4.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	108.01	28.89	8.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.36	24.73	8.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	69.58	26.68	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	94.76	23.29	7.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	94.48	26.33	6.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	82.21	30.59	5.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	96.52	28.32	10.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	145.25	26.68	14.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	90.90	33.97	4.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	108.92	29.40	10.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	100.64	28.64	8.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	73.37	27.77	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	104.83	26.63	11.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	108.01	26.15	7.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	68.92	29.36	4.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	84.49	22.93	8.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	88.79	20.42	7.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	70.29	37.03	3.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	79.96	22.22	9.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	100.79	33.21	9.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	64.07	31.10	3.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	94.24	21.46	8.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	101.94	29.87	10.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	84.65	30.28	4.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	111.37	30.65	9.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	122.81	33.93	10.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	82.70	31.12	4.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	98.76	28.26	9.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	138.07	30.21	12.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	81.47	32.89	4.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	101.65	28.11	11.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	152.73	27.45	10.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	64.43	21.43	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	71.43	21.19	5.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	208.60	38.49	12.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	51.04	14.60	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	96.77	22.36	10.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	94.89	19.04	8.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	58.13	17.75	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.08	34.50	18.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	84.57	14.60	9.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.25	20.50	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	74.42	23.52	9.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	97.95	19.47	6.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	50.54	17.83	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	71.93	20.92	8.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	90.75	19.23	9.01
Schwann Cells, donor1	11498-119F4	21.82	11.10	2.26
Schwann Cells, donor2	11578-120F3	78.26	20.41	6.80
Schwann Cells, donor3	11659-122F3	52.80	10.73	1.75
Sebocyte, donor1	11220-116B5	59.16	20.27	7.12
Sebocyte, donor2	11301-117B5	65.72	17.92	4.14
Sebocyte, donor3	11378-118B1	24.94	7.01	1.65
Sertoli Cells, donor1	11255-116F4	21.54	18.22	4.97
Sertoli Cells, donor2	11333-117F1	36.72	16.95	8.47
Skeletal Muscle Cells, donor1	11281-116I3	53.14	16.54	6.25
Skeletal Muscle Cells, donor2	11358-117H8	6.51	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	24.25	5.02	0.84
Skeletal Muscle Cells, donor4	11451-119A2	81.69	34.09	6.91
Skeletal Muscle Cells, donor5	11455-119A6	70.75	28.09	4.16
Skeletal Muscle Cells, donor6	11459-119B1	91.88	39.25	9.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	92.87	28.10	8.95
Skeletal Muscle Satellite Cells, donor2	11321-117D7	73.20	22.40	6.99
Skeletal Muscle Satellite Cells, donor3	11397-118D2	108.04	31.95	13.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	48.78	17.86	3.71
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.99	6.51	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.80	4.27	0.69
Skin - palm, donor1	10286-104F7	214.89	45.66	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	33.88	9.23	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	148.04	22.90	9.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	40.51	7.01	1.56
Small Airway Epithelial Cells, donor1	11256-116F5	48.10	16.12	9.31
Small Airway Epithelial Cells, donor2	11334-117F2	69.20	14.91	9.71
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	143.36	42.29	11.42
Small Airway Epithelial Cells, donor3	11406-118E2	75.03	18.81	9.44
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	14.50	8.02	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.58	22.23	2.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.39	11.17	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	60.99	17.24	4.20
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.05	5.12	4.33
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.95	6.95	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	73.06	32.02	16.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.55	11.05	3.99
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	39.45	14.19	4.43
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.18	9.99	2.94
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	37.12	11.07	5.54
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	51.68	14.77	6.79
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	27.33	11.39	6.69
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.61	5.86	3.42
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	98.33	26.18	16.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.92	7.07	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	140.78	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	2.38	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.54	14.30	3.10
Smooth Muscle Cells - Colonic, donor2	11320-117D6	44.12	15.28	6.46
Smooth Muscle Cells - Colonic, donor3	11396-118D1	48.39	18.47	6.30
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.28	7.73	3.25
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	7.55	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.91	9.26	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	23.90	6.83	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	60.31	19.24	6.60
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	46.50	9.56	2.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	50.52	23.89	11.15
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	6.64	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	186.51	53.78	19.60
Smooth Muscle Cells - Prostate, donor1	11257-116F6	33.96	19.31	3.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	57.60	17.91	8.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.73	4.82	2.54
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	39.05	8.44	3.62
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	6.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	93.04	19.38	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.81	4.19	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	38.37	7.57	4.04
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	22.88	10.97	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.40	5.60	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	183.03	42.40	17.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	81.29	22.42	7.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.38	7.77	2.88
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.12	10.96	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	15.61	8.09	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	87.20	25.01	7.27
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	33.35	17.26	6.45
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	17.14	6.67	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.01	4.16	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	51.26	28.72	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	30.43	3.80	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.35	14.19	5.05
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.79	10.05	2.38
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	54.68	14.88	4.84
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	81.57	17.61	6.83
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	76.94	13.06	7.10
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	54.75	10.63	2.76
Smooth muscle cells - airway, control, donor1	11966-126D4	44.19	14.98	5.33
Smooth muscle cells - airway, control, donor2	11967-126D5	33.94	13.58	5.59
Smooth muscle cells - airway, control, donor3	11968-126D6	30.10	5.43	4.18
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	7.79	1.83
Synoviocyte, donor1	11291-117A4	33.66	11.11	5.89
Synoviocyte, donor2	11368-117I9	15.76	7.38	2.85
Synoviocyte, donor3	11440-118H9	11.17	8.49	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	61.46	21.08	7.15
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	5.95	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	37.74	16.90	4.86
Tracheal Epithelial Cells, donor1	11292-117A5	41.08	9.39	3.87
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	4.64	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	8.59	2.86	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	112.94	42.94	10.21
Urethra, donor2	10319-105A4	244.59	43.16	12.59
Urothelial Cells, donor1	11520-119H8	22.05	10.36	1.86
Urothelial Cells, donor2	11600-120H7	20.83	6.01	0.40
Urothelial Cells, donor3	11681-122H7	15.36	2.98	0.46
Urothelial cells, donor0	11216-116B1	51.71	11.14	2.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	151.26	63.17	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	135.81	54.33	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	160.18	30.12	6.16
Whole blood (ribopure), donor090325, donation1	12176-128I7	105.71	24.45	3.44
Whole blood (ribopure), donor090325, donation2	12177-128I8	104.58	19.75	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	102.04	37.48	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	113.81	46.81	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	165.23	32.86	3.65
Wilms' tumor cell line:G-401	10809-111A8	85.74	23.07	10.12
Wilms' tumor cell line:HFWT	10597-108E3	104.72	22.88	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	86.59	12.57	5.59
achilles tendon, donor2	10292-104G4	190.12	59.93	28.93
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	209.83	57.88	18.10
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	233.80	46.67	15.32
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	138.77	39.29	15.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	206.81	39.46	13.33
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	152.07	35.42	4.78
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	103.41	24.11	8.25
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	167.41	21.78	7.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	94.74	30.40	10.13
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	108.62	21.23	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	174.35	31.06	15.14
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	105.25	38.27	16.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	85.81	15.60	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	81.57	14.64	3.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	138.25	50.23	12.17
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	130.63	37.70	9.94
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	125.02	29.74	14.87
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	75.67	35.78	16.86
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	198.60	27.32	12.89
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	122.47	34.56	12.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	114.95	36.70	17.89
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	130.70	41.16	11.79
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	103.80	32.52	7.80
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	230.48	39.36	6.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	648.51	141.22	33.45
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	146.90	28.25	6.40
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	372.46	67.60	18.75
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	329.91	86.23	39.36
adenocarcinoma cell line:IM95m	10796-110I4	121.99	23.79	6.36
adipose tissue, adult, pool1	10010-101C1	60.50	24.20	7.45
adipose, donor1	10184-103D4	267.40	38.12	13.49
adipose, donor2	10185-103D5	107.06	10.95	6.89
adipose, donor3	10186-103D6	133.97	25.60	9.53
adipose, donor4	10187-103D7	301.63	27.74	8.67
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	219.05	40.09	9.31
adrenal gland, adult, pool1	10081-102A9	80.03	10.91	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	90.98	13.07	2.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	118.98	29.66	17.51
amniotic membrane cells, donor1	12235-129G3	29.91	6.49	1.39
amniotic membrane cells, donor2	12236-129G4	38.21	7.10	1.01
amniotic membrane cells, donor3	12237-129G5	31.82	4.12	0.00
amygdala - adult, donor10196	10167-103B5	128.07	11.86	4.74
amygdala, adult, donor10252	10151-102I7	127.74	19.47	5.07
amygdala, newborn, donor10223	10360-105E9	90.05	15.17	4.52
anaplastic carcinoma cell line:8305C	10428-106D5	90.66	24.96	6.24
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	89.57	53.39	15.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	123.26	36.74	14.36
aorta, adult, pool1	10052-101G7	60.21	13.73	3.73
appendix, adult	10189-103D9	223.17	43.86	12.03
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	140.33	35.43	17.20
artery, adult	10190-103E1	36.68	17.66	2.72
astrocytoma cell line:TM-31	10425-106D2	67.80	33.46	13.47
b cell line:RPMI1788	10427-106D4	134.57	34.80	7.73
basal cell carcinoma cell line:TE 354.T	10702-109G9	22.47	8.60	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	107.27	32.55	15.08
bile duct carcinoma cell line:TFK-1	10496-107C1	70.47	29.29	8.87
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	57.60	24.61	6.71
bladder, adult, pool1	10011-101C2	86.80	20.10	2.93
blood, adult, pool1	10053-101G8	106.30	37.65	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	89.92	22.27	3.43
bone marrow, adult	10192-103E3	98.52	32.39	11.47
brain, adult, donor1	10084-102B3	46.13	5.13	2.05
brain, adult, pool1	10012-101C3	58.80	11.58	1.67
brain, fetal, pool1	10085-102B4	56.10	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	476.39	30.39	14.87
breast carcinoma cell line:MDA-MB-453	10419-106C5	282.72	25.96	7.36
breast, adult, donor1	10080-102A8	95.33	31.57	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	262.33	32.52	7.11
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	203.16	29.38	14.84
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	547.69	33.15	14.27
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	108.21	18.16	7.75
carcinoid cell line:NCI-H1770	10703-109H1	40.43	7.05	5.64
carcinoid cell line:NCI-H727	10735-110B6	549.31	97.46	36.64
carcinoid cell line:SK-PN-DW	10719-109I8	70.35	19.01	6.34
carcinosarcoma cell line:JHUCS-1	10642-109A3	124.84	29.81	9.05
caudate nucleus - adult, donor10196	10177-103C6	149.67	23.03	6.91
caudate nucleus, adult, donor10252	10164-103B2	109.93	20.08	4.85
caudate nucleus, adult, donor10258	10379-105H1	60.37	5.35	6.11
caudate nucleus, newborn, donor10223	10354-105E3	110.24	22.71	6.59
cerebellum - adult, donor10196	10173-103C2	361.25	32.05	8.74
cerebellum, adult, donor10252	10166-103B4	272.44	45.05	9.39
cerebellum, adult, pool1	10083-102B2	81.06	15.52	2.41
cerebellum, newborn, donor10223	10357-105E6	253.24	19.10	6.64
cerebral meninges, adult	10188-103D8	90.77	18.91	4.79
cerebrospinal fluid, donor2	10294-104G6	89.17	24.12	5.85
cervical cancer cell line:D98-AH2	10552-107I3	35.23	13.52	3.88
cervical cancer cell line:ME-180	10553-107I4	87.33	37.95	14.58
cervix, adult, pool1	10013-101C4	97.64	21.73	3.46
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	60.89	32.05	19.93
chondrosarcoma cell line:SW 1353	10700-109G7	58.78	19.59	5.23
choriocarcinoma cell line:BeWo	10423-106C9	111.60	27.84	14.54
choriocarcinoma cell line:SCH	10785-110H2	79.47	20.82	9.12
choriocarcinoma cell line:T3M-3	10618-108G6	172.43	32.73	10.44
chorionic membrane cells, donor1	12238-129G6	31.34	9.12	2.56
chorionic membrane cells, donor2	12239-129G7	50.11	16.70	3.88
chorionic membrane cells, donor3	12240-129G8	40.66	6.59	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	80.78	36.35	18.18
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	95.67	24.01	6.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	119.32	25.98	9.29
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	195.17	43.14	15.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	217.45	52.49	17.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	218.07	49.88	24.43
chronic myelogenous leukemia cell line:K562	10454-106G4	176.38	64.19	21.79
chronic myelogenous leukemia cell line:KU812	10409-106B4	303.37	74.02	20.33
clear cell carcinoma cell line:JHOC-5	10638-108I8	67.89	8.23	1.83
clear cell carcinoma cell line:TEN	10636-108I6	103.06	18.04	6.59
colon carcinoma cell line:CACO-2	10513-107D9	160.53	51.25	26.18
colon carcinoma cell line:COLO-320	10420-106C6	128.85	16.72	4.56
colon, adult, donor1	10082-102B1	64.26	9.52	0.00
colon, adult, pool1	10014-101C5	114.57	34.31	10.22
colon, fetal, donor1	10070-101I7	144.61	25.96	4.33
common myeloid progenitor CMP, donor1	12130-128D6	403.35	110.00	27.50
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	359.92	122.81	73.09
cord blood derived cell line:COBL-a 24h infection	10453-106G3	235.45	63.99	42.41
cord blood derived cell line:COBL-a untreated	10449-106F8	271.59	67.40	38.21
corpus callosum, adult, pool1	10042-101F6	61.36	11.39	2.65
cruciate ligament, donor2	10295-104G7	147.51	47.01	12.16
diaphragm, fetal, donor1	10069-101I6	85.87	17.66	4.01
diencephalon, adult	10193-103E4	58.32	6.00	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	199.07	43.86	14.01
ductal cell carcinoma cell line:KLM-1	10438-106E6	238.49	78.98	46.67
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	190.17	31.78	23.11
ductus deferens, adult	10196-103E7	119.10	11.46	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	131.06	23.04	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	153.01	14.71	9.56
dura mater, adult, donor1	10041-101F5	57.07	29.57	11.56
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	52.41	59.29	57.07
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	113.92	34.68	20.63
embryonic pancreas cell line:1B2C6	10604-108F1	388.47	64.13	40.08
embryonic pancreas cell line:1C3D3	10605-108F2	151.66	20.28	6.05
embryonic pancreas cell line:1C3IKEI	10606-108F3	372.35	75.95	35.81
embryonic pancreas cell line:2C6	10603-108E9	296.84	52.54	22.33
endometrial carcinoma cell line:OMC-2	10497-107C2	141.45	38.55	21.45
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.03	8.52	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	86.68	8.84	2.89
epidermoid carcinoma cell line:A431	10426-106D3	168.96	54.80	20.68
epidermoid carcinoma cell line:Ca Ski	10431-106D8	127.25	43.44	18.37
epididymis, adult	10197-103E8	75.98	16.74	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.18	3.37	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	126.23	26.35	21.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	157.26	44.43	26.21
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	135.92	46.55	27.07
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	159.53	43.13	28.12
esophagus, adult, pool1	10015-101C6	88.87	17.94	4.25
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	239.58	39.83	11.52
eye - muscle inferior rectus, donor1	10272-104E2	123.14	53.12	14.49
eye - muscle lateral, donor2	10298-104H1	149.40	46.29	10.52
eye - muscle medial, donor2	10299-104H2	126.50	22.32	2.98
eye - muscle superior, donor2	10297-104G9	130.70	37.83	8.03
eye - vitreous humor, donor1	10268-104D7	96.19	32.06	14.57
eye, fetal, donor1	10054-101G9	81.61	14.24	2.80
fibrosarcoma cell line:HT-1080	10758-110E2	67.96	19.62	7.57
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	115.86	45.11	15.19
frontal lobe, adult, pool1	10040-101F4	66.43	11.26	4.88
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	108.69	28.82	17.11
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	127.74	24.69	5.21
gall bladder, adult	10198-103E9	108.40	21.49	6.52
gamma delta positive T cells, donor1	11937-126A2	74.09	15.57	4.83
gamma delta positive T cells, donor2	11938-126A3	66.48	21.66	6.35
gastric adenocarcinoma cell line:MKN1	10614-108G2	46.68	10.56	5.28
gastric adenocarcinoma cell line:MKN45	10612-108F9	263.24	64.02	35.20
gastric cancer cell line:AZ521	10549-107H9	126.25	27.22	13.28
gastric cancer cell line:GSS	10560-108A2	116.23	8.24	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	143.70	67.17	20.56
giant cell carcinoma cell line:LU65	10487-107B1	75.96	29.26	14.00
giant cell carcinoma cell line:Lu99B	10433-106E1	187.83	26.31	16.10
glassy cell carcinoma cell line:HOKUG	10688-109F4	90.79	13.72	3.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	94.15	19.74	5.81
glioblastoma cell line:A172, tech_rep2	10444-106F3	106.59	21.21	7.16
glioblastoma cell line:T98G	10485-107A8	81.01	33.22	14.46
glioma cell line:GI-1	10413-106B8	75.56	24.02	10.25
globus pallidus - adult, donor10196	10175-103C4	121.73	16.76	5.83
globus pallidus, adult, donor10252	10161-103A8	166.47	26.36	5.61
globus pallidus, adult, donor10258	10367-105F7	57.51	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	91.66	12.79	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	320.58	117.46	80.76
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	32.79
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	59.20	12.80	2.88
hIPS +CCl2, biol_rep1	14383-156B9	89.07	22.04	5.51
hIPS +CCl2, biol_rep2	14384-156C1	94.20	21.03	5.94
hIPS +CCl2, biol_rep3	14385-156C2	71.49	19.32	7.73
hIPS, biol_rep1	14380-156B6	116.42	10.06	7.19
hIPS, biol_rep2	14381-156B7	87.79	11.66	7.54
hIPS, biol_rep3	14382-156B8	65.10	7.72	2.21
hairy cell leukemia cell line:Mo	10712-109I1	116.66	28.45	4.88
heart - mitral valve, adult	10205-103F7	94.17	34.38	6.58
heart - pulmonic valve, adult	10206-103F8	86.29	23.27	6.01
heart - tricuspid valve, adult	10207-103F9	134.06	82.43	10.82
heart, adult, diseased post-infarction, donor1	10050-101G5	55.30	15.10	4.29
heart, adult, diseased, donor1	10051-101G6	23.42	3.83	1.70
heart, adult, pool1	10016-101C7	68.99	24.84	1.84
heart, fetal, pool1	10046-101G1	98.16	33.47	6.88
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.94	21.60	4.63
hepatoblastoma cell line:HuH-6	10633-108I3	297.29	101.08	35.68
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	188.62	78.34	43.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	193.23	77.56	44.30
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	209.48	79.43	46.99
hepatoma cell line:Li-7	10484-107A7	71.73	45.60	22.69
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	135.88	42.41	11.56
hippocampus - adult, donor10196	10169-103B7	122.08	18.93	3.79
hippocampus, adult, donor10252	10153-102I9	135.52	21.23	5.31
hippocampus, adult, donor10258	10374-105G5	68.72	5.98	1.49
hippocampus, newborn, donor10223	10363-105F3	101.16	13.39	6.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	150.14	45.17	10.99
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	122.72	26.12	10.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	119.33	26.15	9.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	143.22	16.35	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	199.08	24.27	4.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	154.50	17.08	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	157.65	21.31	9.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	148.86	28.44	10.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	146.39	27.11	15.43
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	90.22	24.39	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	121.02	35.84	17.68
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	82.14	20.20	11.45
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	100.93	22.06	8.45
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	112.51	28.00	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	115.20	19.20	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	183.08	24.25	5.54
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	143.90	23.98	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	169.92	15.49	5.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	119.82	14.51	5.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	118.68	15.92	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	123.10	8.77	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	101.57	23.03	8.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	83.32	24.39	6.68
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	101.93	19.13	6.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	126.37	29.00	10.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	105.56	23.96	7.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	131.48	27.77	10.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	152.10	24.65	5.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	126.38	20.90	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	116.51	16.95	4.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	118.42	17.58	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	130.84	15.94	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	96.71	10.26	5.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	104.82	21.47	4.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	140.84	21.20	9.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	93.42	22.85	8.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	114.96	24.88	6.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	123.45	20.05	9.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	106.34	22.93	11.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	134.17	17.11	6.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	774.27	81.33	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	156.20	20.19	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	134.64	15.32	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	110.74	17.73	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	116.37	19.22	4.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	97.86	26.25	11.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	115.79	30.06	6.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	82.97	18.86	8.62
immature langerhans cells, donor1	11904-125F5	104.37	15.50	6.05
immature langerhans cells, donor2	11905-125F6	144.17	41.19	17.43
insula, adult, pool1	10039-101F3	54.41	9.37	3.69
keratoacanthoma cell line:HKA-1	10791-110H8	39.67	19.18	13.98
kidney, adult, pool1	10017-101C8	119.35	22.83	9.61
kidney, fetal, pool1	10045-101F9	80.64	20.58	6.15
large cell lung carcinoma cell line:IA-LM	10509-107D5	270.27	115.89	37.07
large cell lung carcinoma cell line:NCI-H460	10839-111E2	47.00	16.31	5.39
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	79.27	25.32	7.52
left atrium, adult, donor1	10079-102A7	34.33	10.35	0.00
left ventricle, adult, donor1	10078-102A6	35.40	9.61	2.02
leiomyoblastoma cell line:G-402	10721-110A1	118.75	39.67	14.23
leiomyoma cell line:10964C	10569-108B2	27.30	6.47	2.87
leiomyoma cell line:15242A	10570-108B3	22.28	8.15	1.63
leiomyoma cell line:15425	10571-108B4	45.89	5.83	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	56.46	16.73	12.55
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	158.32	63.75	25.26
liposarcoma cell line:KMLS-1	10782-110G8	55.30	12.97	5.78
liposarcoma cell line:SW 872	10726-110A6	93.33	38.01	25.34
liver, adult, pool1	10018-101C9	55.42	29.33	12.48
liver, fetal, pool1	10086-102B5	86.55	31.98	9.41
locus coeruleus - adult, donor10196	10182-103D2	126.28	21.44	5.25
locus coeruleus, adult, donor10252	10165-103B3	94.49	14.39	3.14
locus coeruleus, adult, donor10258	10375-105G6	49.37	7.90	1.69
locus coeruleus, newborn, donor10223	10362-105F2	167.83	29.02	10.09
lung adenocarcinoma cell line:A549	10499-107C4	64.08	12.18	4.01
lung adenocarcinoma cell line:PC-14	10408-106B3	237.85	39.99	11.72
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	587.50	84.76	69.20
lung, adult, pool1	10019-101D1	131.71	38.39	9.92
lung, fetal, donor1	10068-101I5	317.94	107.31	12.56
lung, right lower lobe, adult, donor1	10075-102A3	126.47	52.69	9.16
lymph node, adult, donor1	10077-102A5	92.78	22.25	5.68
lymphangiectasia cell line:DS-1	10727-110A7	133.70	42.74	13.37
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	161.94	34.26	13.89
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	226.82	50.12	23.79
mature adipocyte, donor1	12231-129F8	73.26	31.52	15.10
mature adipocyte, donor2	12232-129F9	87.58	20.13	11.00
mature adipocyte, donor3	12233-129G1	76.33	30.11	13.28
mature adipocyte, donor4	12234-129G2	61.07	22.90	13.42
maxillary sinus tumor cell line:HSQ-89	10414-106B9	550.14	84.11	35.98
medial frontal gyrus - adult, donor10196	10170-103B8	127.47	19.18	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	152.83	32.18	8.83
medial frontal gyrus, adult, donor10258	10368-105F8	49.88	7.31	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	185.52	20.90	9.81
medial temporal gyrus - adult, donor10196	10183-103D3	142.76	20.59	4.73
medial temporal gyrus, adult, donor10252	10156-103A3	168.29	26.95	5.52
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1205.70	71.77	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	100.14	16.15	3.95
medulla oblongata - adult, donor10196	10174-103C3	116.82	31.80	9.73
medulla oblongata, adult, donor10252	10155-103A2	141.18	24.15	6.04
medulla oblongata, adult, pool1	10038-101F2	41.87	11.43	2.45
medulla oblongata, newborn, donor10223	10361-105F1	90.27	20.83	5.21
medulloblastoma cell line:D283 Med	10838-111E1	122.22	45.39	4.87
medulloblastoma cell line:ONS-76	10759-110E3	174.24	52.70	19.07
melanoma cell line:COLO 679	10514-107E1	65.69	29.04	13.66
melanoma cell line:G-361	10465-106H6	45.61	14.39	4.89
meningioma cell line:HKBMM	10691-109F7	47.04	8.68	2.35
merkel cell carcinoma cell line:MKL-1	10843-111E6	213.24	37.89	25.55
merkel cell carcinoma cell line:MS-1	10844-111E7	143.87	39.92	15.03
mesenchymal precursor cell - adipose, donor1	11747-123G1	48.02	14.88	2.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	33.63	14.00	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.54	8.70	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	29.22	12.92	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	28.69	10.40	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.70	12.49	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	32.95	10.98	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	34.16	12.42	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	43.77	14.46	1.99
mesenchymal precursor cell - cardiac, donor4	11755-123G9	41.86	17.29	2.30
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	59.75	24.18	5.41
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.42	22.07	12.19
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	50.64	19.23	4.43
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	61.44	17.45	5.24
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.52	9.19	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	41.70	10.42	8.99
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.14	8.28	1.76
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	27.81	7.98	3.65
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	54.12	13.43	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	35.42	15.54	3.89
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.28	15.41	3.50
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.77	12.52	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	42.07	14.31	5.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	67.78	12.63	6.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	3.20	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.58	5.63	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	20.94	6.02	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.34	5.55	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.48	6.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.03	5.08	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.51	4.32	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.41	5.10	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.01	9.23	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.99	5.80	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.12	7.21	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	49.13	7.33	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	23.83	7.05	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	35.21	6.55	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.79	6.01	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	10.33	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.50	9.74	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	8.73	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	34.65	7.46	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	37.62	12.27	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	34.60	8.55	4.28
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	2.10	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	6.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	14.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	34.98	10.67	4.74
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	47.52	4.87	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	47.50	10.77	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.97	4.48	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	4.07	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	8.74	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.86	13.56	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.77	6.23	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	14.70	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	15.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	61.63	25.68	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	29.60	15.14	6.20
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	29.69	21.77	10.39
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	22.43	12.34
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.80	21.63	11.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	24.18	11.28	10.07
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	8.72	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	8.87	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	23.06	8.50	7.89
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	36.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.89	7.41	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.22	12.30	3.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.85	12.33	5.84
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	10.19	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	89.75	13.15	6.19
mesothelioma cell line:ACC-MESO-1	10493-107B7	109.14	32.13	11.34
mesothelioma cell line:ACC-MESO-4	10494-107B8	91.74	35.21	15.75
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	76.92	8.55	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	61.65	15.93	5.96
mesothelioma cell line:Mero-25	10850-111F4	56.28	22.01	7.04
mesothelioma cell line:Mero-41	10851-111F5	71.39	12.71	4.89
mesothelioma cell line:Mero-48a	10852-111F6	81.04	13.95	3.99
mesothelioma cell line:Mero-82	10853-111F7	57.29	24.97	13.93
mesothelioma cell line:Mero-83	10854-111F8	51.75	12.77	3.23
mesothelioma cell line:Mero-84	10855-111F9	43.48	11.37	2.27
mesothelioma cell line:Mero-95	10856-111G1	63.77	19.46	8.28
mesothelioma cell line:NCI-H2052	10847-111F1	94.92	22.36	7.29
mesothelioma cell line:NCI-H226	10846-111E9	51.58	15.57	6.33
mesothelioma cell line:NCI-H2452	10848-111F2	75.50	13.49	6.32
mesothelioma cell line:NCI-H28	10845-111E8	58.02	12.72	1.53
mesothelioma cell line:No36	10857-111G2	43.71	11.42	1.96
mesothelioma cell line:ONE58	10858-111G3	63.94	16.80	11.11
migratory langerhans cells, donor1	11901-125F2	109.97	10.94	2.11
migratory langerhans cells, donor2	11902-125F3	69.73	6.84	3.30
migratory langerhans cells, donor3	11903-125F4	76.10	7.36	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	64.32	32.97	9.47
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	48.32	21.41	9.33
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	275.74	72.79	36.40
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	85.06	22.26	12.56
myelodysplastic syndrome cell line:SKM-1	10772-110F7	115.13	50.26	21.25
myeloma cell line:PCM6	10474-106I6	64.24	16.80	2.97
myxofibrosarcoma cell line:MFH-ino	10600-108E6	106.02	45.66	8.12
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.47	25.50	6.67
nasal epithelial cells, donor1, tech_rep1	12226-129F3	37.77	10.70	3.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	53.46	10.08	3.90
nasal epithelial cells, donor2	12227-129F4	59.06	9.38	2.76
neuroblastoma cell line:CHP-134	10508-107D4	187.50	92.94	22.32
neuroblastoma cell line:NB-1	10539-107G8	125.53	45.46	10.48
neuroblastoma cell line:NBsusSR	10607-108F4	66.22	52.51	27.20
neuroblastoma cell line:NH-12	10555-107I6	119.26	32.05	6.52
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	111.97	28.47	7.12
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	127.02	38.17	12.35
neuroectodermal tumor cell line:TASK1	10774-110F9	63.80	26.16	6.44
neuroepithelioma cell line:SK-N-MC	10728-110A8	168.48	38.78	17.80
neurofibroma cell line:Hs 53.T	10729-110A9	37.53	13.04	6.39
neutrophil PMN, donor1	12133-128D9	119.00	59.50	44.62
neutrophil PMN, donor2	12137-128E4	13.28	26.56	13.28
neutrophil PMN, donor3	12141-128E8	9.47	18.94	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	151.87	35.35	15.22
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	79.25	9.61	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	27.89	11.22	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.26	8.67	3.68
nucleus accumbens, adult, pool1	10037-101F1	58.87	14.15	3.75
occipital cortex - adult, donor10196	10172-103C1	191.62	41.21	6.18
occipital cortex, adult, donor10252	10163-103B1	171.48	23.88	8.86
occipital cortex, newborn, donor10223	10355-105E4	127.02	13.83	3.64
occipital lobe, adult, donor1	10076-102A4	94.20	16.01	2.89
occipital lobe, fetal, donor1	10073-102A1	223.99	35.62	7.29
occipital pole, adult, pool1	10036-101E9	31.06	7.17	0.87
olfactory region, adult	10195-103E6	88.46	11.46	1.72
optic nerve, donor1	10277-104E7	172.09	24.01	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	92.49	24.38	9.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	86.42	17.86	3.43
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	74.50	18.46	7.79
oral squamous cell carcinoma cell line:SAS	10544-107H4	68.03	33.50	10.40
osteoclastoma cell line:Hs 706.T	10704-109H2	22.34	7.35	2.94
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	592.37	306.46	123.33
osteosarcoma cell line:HS-Os-1	10558-107I9	65.31	24.60	7.00
ovary, adult, pool1	10020-101D2	74.86	22.97	3.41
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	62.33	29.51	6.42
pancreas, adult, donor1	10049-101G4	47.97	13.17	5.64
pancreatic carcinoma cell line:NOR-P1	10698-109G5	106.22	28.51	9.78
papillary adenocarcinoma cell line:8505C	10437-106E5	104.43	26.92	16.01
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	159.46	32.29	7.95
paracentral gyrus, adult, pool1	10035-101E8	53.08	13.73	3.66
parietal cortex, adult, donor10258	10373-105G4	106.43	5.14	1.47
parietal lobe - adult, donor10196	10171-103B9	108.16	21.63	2.82
parietal lobe, adult, donor10252	10157-103A4	145.94	26.79	5.70
parietal lobe, adult, pool1	10034-101E7	45.03	12.25	2.82
parietal lobe, fetal, donor1	10072-101I9	250.22	32.97	10.67
parietal lobe, newborn, donor10223	10356-105E5	136.83	17.20	10.09
parotid gland, adult	10199-103F1	62.28	12.33	3.08
penis, adult	10200-103F2	54.25	17.19	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	71.03	23.43	3.90
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	77.07	25.50	16.03
pineal gland - adult, donor10196	10179-103C8	258.66	45.15	8.39
pineal gland, adult, donor10252	10160-103A7	260.57	57.44	9.48
pineal gland, adult, donor10258	10377-105G8	127.30	11.91	3.76
pituitary gland - adult, donor10196	10180-103C9	197.30	42.50	3.04
pituitary gland, adult, donor10252	10162-103A9	274.66	80.78	18.24
pituitary gland, adult, donor10258	10378-105G9	111.51	17.02	3.40
placenta, adult, pool1	10021-101D3	131.37	38.59	18.71
plasma cell leukemia cell line:ARH-77	10840-111E3	103.69	30.59	10.73
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	73.93	15.72	4.36
pons, adult, pool1	10033-101E6	54.31	12.05	4.48
postcentral gyrus, adult, pool1	10032-101E5	38.53	7.15	2.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	100.39	48.10	46.01
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	88.42	13.11	10.63
prostate cancer cell line:PC-3	10439-106E7	270.26	62.62	25.59
prostate, adult, pool1	10022-101D4	79.99	18.59	3.36
putamen, adult, donor10196	10176-103C5	125.11	19.59	6.14
putamen, adult, donor10252	10152-102I8	58.82	7.84	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	61.20	15.30	5.46
putamen, adult, donor10258, tech_rep2	10372-105G3	66.68	11.60	1.69
putamen, newborn, donor10223	10365-105F5	184.42	31.49	9.75
rectal cancer cell line:TT1TKB	10469-106I1	294.43	90.19	28.51
rectum, fetal, donor1	10067-101I4	191.96	25.04	8.35
renal cell carcinoma cell line:OS-RC-2	10411-106B6	80.35	10.60	4.24
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	32.31	2.90	0.00
retina, adult, pool1	10030-101E3	63.62	15.31	4.27
retinoblastoma cell line:Y79	10475-106I7	110.94	41.05	14.81
rhabdomyosarcoma cell line:KYM-1	10787-110H4	105.24	23.48	6.76
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	359.09	139.76	32.34
sacrococcigeal teratoma cell line:HTST	10695-109G2	58.35	49.26	14.40
salivary acinar cells, donor1	11771-123I7	44.02	18.61	3.88
salivary acinar cells, donor2	11772-123I8	30.98	11.98	2.89
salivary acinar cells, donor3	11773-123I9	99.97	25.82	9.27
salivary gland, adult, pool1	10093-102C3	35.46	6.86	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	127.48	36.76	24.20
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	115.55	35.85	24.80
seminal vesicle, adult	10201-103F3	146.02	21.16	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	92.80	13.36	7.04
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	32.46	8.05	2.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	73.26	5.02	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	111.35	20.82	10.21
signet ring carcinoma cell line:Kato III	10436-106E4	148.44	32.94	19.89
signet ring carcinoma cell line:NUGC-4	10483-107A6	92.90	16.13	6.97
skeletal muscle - soleus muscle, donor1	10282-104F3	87.25	22.70	9.93
skeletal muscle, adult, pool1	10023-101D5	51.93	17.51	4.32
skeletal muscle, fetal, donor1	10066-101I3	51.26	18.09	3.02
skin, adult, donor1	10074-102A2	67.85	0.00	0.00
skin, fetal, donor1	10065-101I2	100.37	17.67	6.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	96.72	31.35	19.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	134.91	61.78	19.86
small cell lung carcinoma cell line:DMS 144	10841-111E4	87.70	8.67	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	56.04	15.33	9.07
small cell lung carcinoma cell line:NCI-H82	10842-111E5	78.66	18.66	4.34
small cell lung carcinoma cell line:WA-hT	10562-108A4	76.27	18.52	6.10
small intestine, adult, pool1	10024-101D6	219.78	42.28	18.99
small intestine, fetal, donor1	10064-101I1	99.75	22.85	8.35
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	110.27	14.36	6.15
smooth muscle, adult, pool1	10048-101G3	70.82	20.16	3.10
somatostatinoma cell line:QGP-1	10781-110G7	156.26	45.83	20.64
spinal cord - adult, donor10196	10181-103D1	157.83	20.42	3.44
spinal cord, adult, donor10252	10159-103A6	111.18	20.50	1.58
spinal cord, adult, donor10258	10369-105F9	88.55	5.53	2.08
spinal cord, fetal, donor1	10056-101H2	114.65	17.69	5.49
spinal cord, newborn, donor10223	10359-105E8	143.27	28.93	8.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	37.94	15.23	5.53
spleen, adult, pool1	10025-101D7	111.90	39.54	13.55
spleen, fetal, pool1	10044-101F8	93.76	27.33	8.02
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	187.36	29.71	8.28
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	56.20	13.67	4.37
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	91.56	19.92	8.74
squamous cell carcinoma cell line:T3M-5	10616-108G4	241.60	75.45	25.80
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	95.34	49.30	25.66
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	117.34	11.44	4.24
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	78.69	19.88	12.27
stomach, fetal, donor1	10062-101H8	205.05	55.53	11.75
submaxillary gland, adult	10202-103F4	97.42	15.38	1.71
substantia nigra - adult, donor10196	10178-103C7	868.39	108.55	54.27
substantia nigra, adult, donor10252	10158-103A5	111.33	14.54	3.12
substantia nigra, adult, donor10258	10371-105G2	49.66	4.14	0.52
substantia nigra, newborn, donor10223	10358-105E7	122.24	21.90	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	178.37	22.47	8.02
temporal lobe, adult, pool1	10031-101E4	37.13	5.59	1.61
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	190.89	31.34	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	144.17	20.66	3.08
tenocyte, donor1	11763-123H8	37.00	9.08	1.75
tenocyte, donor2	11765-123I1	27.85	6.10	2.29
tenocyte, donor3	11768-123I4	30.02	5.56	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	118.46	45.72	25.83
teratocarcinoma cell line:NCR-G1	10798-110I6	133.95	40.23	10.17
teratocarcinoma cell line:PA-1	10807-111A6	88.65	35.49	11.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	82.26	27.17	9.65
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	266.23	40.46	15.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	162.72	63.58	6.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	201.28	27.68	11.07
testis, adult, pool1	10026-101D8	70.97	17.72	3.65
testis, adult, pool2	10096-102C6	92.47	16.24	2.71
thalamus - adult, donor10196	10168-103B6	134.69	26.50	3.31
thalamus, adult, donor10252	10154-103A1	127.21	19.07	5.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	60.05	6.16	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.49	8.07	1.48
thalamus, newborn, donor10223	10366-105F6	75.94	13.81	5.75
throat, adult	10209-103G2	102.36	20.47	3.99
throat, fetal, donor1	10061-101H7	109.69	17.37	4.27
thymic carcinoma cell line:Ty-82	10803-111A2	153.02	21.26	3.58
thymus, adult, pool1	10027-101D9	202.41	52.49	14.51
thymus, fetal, pool1	10043-101F7	172.59	56.84	16.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	115.14	26.33	9.71
thyroid carcinoma cell line:TCO-1	10783-110G9	116.08	33.81	14.11
thyroid, adult, pool1	10028-101E1	133.62	27.81	5.60
thyroid, fetal, donor1	10060-101H6	155.82	23.20	4.22
tongue epidermis (fungiform papillae), donor1	10288-104F9	147.82	24.64	18.48
tongue, adult	10203-103F5	81.40	15.58	6.51
tongue, fetal, donor1	10059-101H5	87.49	20.49	2.76
tonsil, adult, pool1	10047-101G2	85.85	20.14	3.81
trachea, adult, pool1	10029-101E2	100.12	28.30	8.75
trachea, fetal, donor1	10058-101H4	122.72	23.47	6.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	71.92	20.55	11.69
transitional-cell carcinoma cell line:5637	10418-106C4	173.56	53.19	25.94
transitional-cell carcinoma cell line:JMSU1	10492-107B6	112.34	29.14	14.42
tridermal teratoma cell line:HGRT	10694-109G1	161.72	68.49	11.42
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	109.54	38.18	25.14
umbilical cord, fetal, donor1	10057-101H3	64.68	10.43	12.52
uterus, adult, pool1	10100-102D1	56.99	20.82	1.71
uterus, fetal, donor1	10055-101H1	116.21	13.82	1.54
vagina, adult	10204-103F6	116.32	47.82	5.82
vein, adult	10191-103E2	100.83	22.80	5.70
xeroderma pigentosum b cell line:XPL 17	10563-108A5	82.25	14.69	4.27